CTT $10.37 0%
IPA $3.34 15.564%
0063.HK $0.12 -1.6529%
SLCRU $7.40 0%
BNGOW $0.06 1.3986%
1034.HK $0.48 -19.4915%
0732.HK $0.93 -1.0638%
CHPMU $10.15 0%
0712.HK $0.12 5.9829%
BNDD $15.52 0.4875%
BRW $7.92 0.3169%
9688.HK $27.45 -4.8527%
AACQU $11.05 0%
AMPGW $0.43 1.4068%
MGIC $14.23 0%
EQC-PD $25.68 2.6071%
VIACA $32.83 0%
FREQ.L $27.98 -3.42625%
BY $16.99 -0.147%
SMMU $49.65 -0.0503%
SMHI $7.75 -1.8987%
0434.HK $0.50 0%
PTTRX $8.68 0.2309%
QTUM $43.85 -0.8367%
UKG5.L $942.18 0.0774%
1639.HK $1.82 0%
RNW $5.27 0.6692%
AXDX $0.75 -0.04%
GHVI $14.47 0%
0369.HK $3.44 0.5848%
GCACW $0.50 0%
JRNY $22.41 -0.1644%
NEO $19.10 -3.6813%
AMC.L $1.70 1.4948%
EVY $15.17 0%
J13E.L $83.14 0.1596%
MFB.NZ $0.19 -0.5348%
MLCO $11.18 -3.414%
CMSD $24.38 0.2879%
0QFK.L $0.61 -5%
SEM $28.21 -0.3884%
VTIQU $10.06 0%
1203.HK $0.65 -1.5152%
EJH $0.25 -3.8462%
SONO $15.76 -2.3854%
FLXG.L $26.82 -6.69798%
LNG $147.32 0.2143%
8091.HK $0.04 2.63158%
2823.HK $14.04 -1.5428%
TZOO $9.02 0%
VLU.L $35.50 0%
3638.HK $0.57 0%
LCID $7.00 -0.9207%
0711.HK $0.52 0%
REKR $1.28 -5.1852%
XESJ.L $15.65 2.4825%
SISI $0.55 3.8293%
1578.HK $1.89 -0.5263%
0OJJ.L $4.36 0%
PCFT.L $136.20 0.4425%
VONE $185.80 -0.7479%
INDT $66.74 0.06%
DUET $10.45 -0.0478%
VSH $23.98 -1.681%
CSLMU $10.34 0%
DBEF $36.06 0.2085%
ARS.L $0.98 -4.878%
OVH.PA $10.50 8.3033%
LOV $0.86 0%
TPOU.L $19.70 0.7673%
NVSAU $10.15 0%
0LK3.L $239.42 0.4531%
MLBSP.PA $3.78 0%
PRS $24.45 0.4107%
CFBK $16.00 3.8961%
ILMN $207.90 -0.1489%
MBTCU $10.94 0%
LDHAW $0.00 0%
2208.HK $6.09 -2.7157%
FSZ $62.97 -0.1427%
TDS-PU $11.33 -2.8302%
FUSD.L $8.36 -0.2537%
HRL $40.19 -0.2606%
BAP $136.86 -2.9362%
2028.HK $0.16 0%
2372.HK $0.46 3.4091%
OXAC $10.86 0%
SATL $2.22 -1.3333%
0209.HK $0.14 0%
JT13.L $695.35 -0.3297%
GCMG $6.95 -2.7972%
MWA $13.42 -1.4328%
0347.HK $2.52 -5.2632%
TGTX $31.09 -7.7722%
ARE.L $20.75 0%
MBO.L $5.25 -12.5%
CYT $2.16 -0.6912%
1665.HK $1.10 -1.7857%
MLNMA.PA $0.70 0%
Eng
Логотип
Eng
Лого

Venus Medtech (Hangzhou) Inc. 2500.HK

$8.90

-$0.64 (-7.20%)
На 18:03, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    4273386745.00000000

  • week52high

    18.96

  • week52low

    8.18

  • Revenue

    406461000

  • P/E TTM

    -11

  • Beta

    0.18433800

  • EPS

    -1.17000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    31 мар 2023 г. в 10:59

Описание компании

Venus Medtech (Hangzhou) Inc. develops and commercializes transcatheter heart valve medical devices in Mainland China and internationally. The company's products include VenusA-Valve, a transcatheter aortic heart valve replacement (TAVR) product to treat severe aortic stenosis; VenusP-Valve is a transcatheter pulmonary valve system to treat the dysfunction of right ventricular outflow tract; V8/TAV8 balloon aortic valvuloplasty catheter systems; and TriGUARD3, a cerebral embolic protection device for minimizing the risk of brain damage and prevent cerebral embolism during TAVR and other structural heart disease surgeries. It also develops VenusA-Plus and VenusA-Pilot, which are TAVR product candidates; and transcatheter mitral and tricuspid valve replacement products; Liwen RF ablation system for the treatment of hypertrophic cardiomyopathy; and renal denervation for the treatment of hypertension. The company was founded in 2009 and is headquartered in Hangzhou, the People's Republic of China.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек